Shalini Sharp
Independent DirectorMs. Shalini Sharp MBA, is Director of Alameda County Community Food Bank, Inc. Ms. Sharp is Independent Non-Executive Director of BeOne Medicines Ltd. (formerly known as BeiGene, Ltd.) from September 27, 2024. She serves as Independent Director at Iambic Therapeutics, Inc. since September 2025. She is Independent Director of Septerna, Inc. from January 2024. She has been an Independent Director at Organon & Co. since June 2, 2021. She served an Independent Director at Sutro Biopharma, Inc. since November 8, 2018 until April 10, 2023. She served as an Independent Director at Mirati Therapeutics, Inc. since March 26, 2021 until January 23, 2024. She was the Executive Vice President of Finance at Ultragenyx Pharmaceutical Inc since October 2020 until 2020. She has been Independent Director of Neurocrine Biosciences, Inc. since February 2020. She served as a Director of Precision BioSciences, Inc. since December 2018 until May 10, 2022. She served as Independent Director of Panacea Acquisition Corp. since July 2020 until February 2021. She has been Treasurer and Vice President of Dimension Therapeutics, Inc. since November 7, 2017. She was the Chief Financial Officer and Executive Vice President at Ultragenyx Pharmaceutical Inc. since May 2012 until October 2020. She is responsible for leading the corporate finance, strategy and information technology functions and is a Member of its executive leadership team. She has also developed a deep expertise in critical strategic, business development and financial issues facing companies like Array. She served as Senior Vice President of Ultragenyx Pharmaceutical Inc. from May 21, 2012 to January 2016 and served as its Principal Accounting Officer until March 24, 2014. She served as Senior Vice President of Ultragenyx Pharmaceutical, Inc. since May 2012. She served as the Chief Financial Officer and Vice President of Antigenics Inc. from September 9, 2006 to May 2012. She served as a Vice President of Agenus Inc. (formerly, Antigenics Inc.) from September 30, 2006 to May 11, 2012 and also served as its Senior Director of Strategic Planning and Corporate development. Prior to joining Ultragenyx, between 2006 and 2012, she served as the Chief Financial Officer of Agenus Inc., where between 2003 and 2006 she served in various finance, corporate development and corporate strategy roles. She joined Agenus in 2003. She serves as Strategic Advisor to Ultragenyx Pharmaceutical Inc. She held increasing roles of responsibility at Agenus spanning strategy, finance and business development since 2003 until 2006. She served as Senior Director of Strategic Planning and Corporate Development of Antigenics Inc. since 2003. In this position she managed strategic planning, Investor Relations and financing & acquisition transactions. She held similar roles at Elan Pharmaceuticals from 1998 to 2003, including serving as Chief of Staff to the Chairman of the Board of Directors from August 1998 to August 1999 and September 2001 to August 2003 during its restructuring. She has spearheaded numerous financing and business development transactions that were critical to the success of Agenus and Elan. She served as Director of Strategic Planning at Elan Corporation Plc. She was a Management Consultant of McKinsey & Company and was an Investment Banker at Goldman Sachs, specialized in pharmaceuticals and medical devices. She served as an Independent Director of Array BioPharma Inc. since April 27, 2017 until July 30, 2019. She served as a Director of Agenus Inc. since May 11, 2012 until June 2018. She serves as a Member of The Board of Directors of the TB Alliance. She has worked in investment banking at Goldman, Sachs & Company, primarily in the health care field. She obtained her B.A. in English and American Literature and Languages from Harvard College and her M.B.A. from Harvard Business School.
公司職務
- 公司名稱Organon & Co.股票代碼OGN職務Independent Director共事同僚
- CSCarrie Smith CoxExecutive Chair of the Board
- JTJoseph T. MorrisseyChief Executive Officer
- MMMatthew M. WalshExecutive VP & CFO
- RARachel A. StahlerExecutive VP, Chief Information Officer and Chief Digital & Growth Officer
- KWKirke WeaverExecutive VP, General Counsel & Corporate Secretary
- SSShalini SharpIndependent Director
- RARobert Alan EssnerLead Independent Director
- RAR. Alan B. EzekowitzIndependent Director
- HDHelene D. GayleIndependent Director
- 公司名稱Neurocrine Biosciences, Inc.股票代碼NBIX職務Independent Director共事同僚
- KWKyle W. GanoPresident, CEO & Director
- WHWilliam H. RastetterIndependent Chairman of the Board
- MCMatthew C. AbernethyChief Financial Officer
- JOJude OnyiaChief Scientific Officer
- ESEric S. BenevichChief Commercial Officer
- EWEiry Wyn RobertsChief Medical Officer
- RFRichard F. PopsIndependent Director
- LVLeslie V. NorwalkIndependent Director
- SSShalini SharpIndependent Director
- 公司名稱百濟神州有限公司股票代碼06160職務Independent Non-Executive Director共事同僚
- JVJohn V. OylerCo-Founder, Executive Chairman & CEO
- WLWang LaiPresident and Global Head of Research & Development
- XWXiaodong WangCo-Chairman of Scientific Advisory Board, Non-Executive Director & Co-Founder
- ARAaron RosenbergChief Financial Officer
- CLChan LeeGeneral Counsel, Senior VP & Corporate Secretary
- ACAnthony C. HooperChairman of Commercial & Medical Affairs Advisory Committee and Ind. Non Executive Director
- MHMargaret Han DuganMember of Scientific Advisory Committee & Independent Non-Exec. Director
- SSShalini SharpIndependent Non-Executive Director
- 公司名稱Iambic Therapeutics, Inc.股票代碼IAM職務Independent Director共事同僚
- TMThomas MillerCo-Founder, CEO, Secretary & Director
- WHWilliam H. RastetterIndependent Chairperson
- FRFrederick R. ManbyCo-Founder, CTO & Director
- MSMichael SecoraChief Corporate Development Officer & CFO
- PAPeter A. OlsonChief Scientific Officer
- SCSunny ChangGeneral Counsel
- MTMary TagliaferriIndependent Director
